PD-L2 is expressed on activated human T cells and regulates their function

• The cosignaling molecule, PD-L2 is expressed on human activated T cell subsets. • The PD-L2 triggering down-regulates (TCR+CD28)-induced cytokine production on human T cells. • A direct targeting of PD-L2 on T cells blocks T cell proliferation. T-cell activation and proliferation are regulated by...

Full description

Saved in:
Bibliographic Details
Published inMolecular immunology Vol. 48; no. 15-16; pp. 2214 - 2219
Main Authors Messal, Nassima, Serriari, Nacer-Eddine, Pastor, Sonia, Nunès, Jacques A., Olive, Daniel
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:• The cosignaling molecule, PD-L2 is expressed on human activated T cell subsets. • The PD-L2 triggering down-regulates (TCR+CD28)-induced cytokine production on human T cells. • A direct targeting of PD-L2 on T cells blocks T cell proliferation. T-cell activation and proliferation are regulated by cosignaling adhesion molecules involved in positive or negative signals. Programmed death (PD)-1 is one of immune inhibitory molecules that is expressed in activated T cells and is a promising target for immunotherapy. Both PD-1 ligands, PD-L1 and PD-L2 are expressed on antigen presenting cells (APCs) involved in the dialogue between a T cell and an APC. Here, we analysed the expression of these ligands, especially for PD-L2, on T cells. PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation. These observations indicate that PD-L2 is expressed following activation and is involved in the regulation of T cell function, highlighting the level of complexity in the T cell cosignaling network.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0161-5890
1872-9142
DOI:10.1016/j.molimm.2011.06.436